As Indian drug giants rush to export weight-loss drug semaglutide in countries that don’t have patent exclusivity, they face an unlikely adversary in their neighbour.
​As Indian drug giants rush to export weight-loss drug semaglutide in countries that don’t have patent exclusivity, they face an unlikely adversary in their neighbour. by Soban News (international And National News)
